Published in J Neurooncol on January 08, 2010
Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol (2013) 1.30
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging (2014) 1.10
Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol (2011) 1.08
Treatment of Brain Metastases. J Clin Oncol (2015) 1.03
Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol (2013) 0.97
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro Oncol (2015) 0.96
MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study. Neuroradiology (2010) 0.88
Updates in the management of brain metastases. Neuro Oncol (2016) 0.88
ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol (2015) 0.84
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis. PLoS One (2016) 0.82
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice. Neurosurg Rev (2013) 0.82
Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression. Eur Radiol (2012) 0.82
Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging. J Neurooncol (2011) 0.80
Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol (2014) 0.78
Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours. Neuroradiol J (2015) 0.77
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma. BMC Cancer (2015) 0.75
Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab. Fluids Barriers CNS (2016) 0.75
Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases. Transl Lung Cancer Res (2016) 0.75
False-positive magnetic resonance imaging findings in follow-up of pediatric patients with tumors of the central nervous system. SAGE Open Med Case Rep (2016) 0.75
Double trouble: a tale of two radio-treatments. BMJ Case Rep (2014) 0.75
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives. J Immunol Res (2017) 0.75
Amino acid PET and MR perfusion imaging in brain tumours. Clin Transl Imaging (2017) 0.75
Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method. Neuroradiology (2015) 0.75
Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI. Neuro Oncol (2017) 0.75
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys (2003) 3.43
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol (2005) 2.35
Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One (2011) 1.73
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis. J Thorac Oncol (2010) 1.68
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med (2010) 1.66
Patterns of practice in palliative radiotherapy for painful bone metastases: a survey in Japan. Int J Radiat Oncol Biol Phys (2012) 1.60
Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction. Gastric Cancer (2012) 1.60
Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer (2011) 1.54
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 1.49
Early phase II study of robot-assisted distal gastrectomy with nodal dissection for clinical stage IA gastric cancer. Gastric Cancer (2013) 1.43
Deaths within 12 months after (125)I implantation for brachytherapy of prostate cancer: an investigation of radiation safety issues in Japan (2003-2010). Brachytherapy (2011) 1.38
Physical performance evaluation of a 256-slice CT-scanner for four-dimensional imaging. Med Phys (2004) 1.31
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports. Cancer Sci (2011) 1.30
Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol (2012) 1.29
Risk of lymph node metastases from intramucosal gastric cancer in relation to histological types: how to manage the mixed histological type for endoscopic submucosal dissection. Gastric Cancer (2012) 1.28
Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol (2010) 1.27
Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate? J Cancer Res Clin Oncol (2010) 1.24
Guanidinium tetra-bromidomercurate(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.21
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer (2009) 1.19
Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer. Radiother Oncol (2010) 1.18
Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study. Cancer (2010) 1.18
Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol (2012) 1.17
Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column: a review of 544 patients at Shizuoka Cancer Center Hospital. Cancer (2008) 1.17
LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer. Am J Transl Res (2011) 1.16
Enlarged longitudinal dose profiles in cone-beam CT and the need for modified dosimetry. Med Phys (2005) 1.12
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One (2011) 1.11
Electron density measurement with dual-energy x-ray CT using synchrotron radiation. Phys Med Biol (2003) 1.10
The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol (2011) 1.08
Intestinal obstruction in the terminal ileum caused by an anomalous congenital vascular band between the mesoappendix and the mesentery: report of a case. Surg Today (2004) 1.07
Long-term survivors of more than 5 years in advanced non-small cell lung cancer. Lung Cancer (2010) 1.04
Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol (2010) 1.03
Pituicytoma. Two case reports. Neurol Med Chir (Tokyo) (2006) 1.03
Metastatic skull tumors: MRI features and a new conventional classification. J Neurooncol (2010) 1.02
A combination-weighted Feldkamp-based reconstruction algorithm for cone-beam CT. Phys Med Biol (2006) 1.02
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure. Lung Cancer (2011) 1.02
Acute lung injury with alveolar hemorrhage as adverse drug reaction related to crizotinib. J Clin Oncol (2013) 1.02
Japanese structure survey of radiation oncology in 2005 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2008) 1.01
New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med (2014) 1.01
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study. Cancer (2014) 1.01
Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study. BMC Cancer (2013) 1.00
Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors. J Nucl Med (2011) 1.00
Radiotherapy for patients with symptomatic intramedullary spinal cord metastasis. J Radiat Res (2011) 1.00
Omental flap in pancreaticoduodenectomy for protection of splanchnic vessels. World J Surg (2005) 1.00
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer. Lung Cancer (2009) 1.00
[New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. Gan To Kagaku Ryoho (2009) 0.99
Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer. J Thorac Oncol (2007) 0.98
Comparison of the effects of high-energy photon beam irradiation (10 and 18 MV) on 2 types of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol Phys (2012) 0.98
Characterization of a class II defective transposon carrying two haloacetate dehalogenase genes from Delftia acidovorans plasmid pUO1. Appl Environ Microbiol (2002) 0.98
Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification. J Gastrointest Surg (2011) 0.98
Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer. Anticancer Res (2012) 0.97
Irradiation System for HIMAC. J Radiat Res (2007) 0.97
Effective doses in subjects undergoing computed tomography cardiac imaging with the 256-multislice CT scanner. Eur J Radiol (2007) 0.94
Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology (2008) 0.94
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas. Cancer Sci (2012) 0.93
L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma. Anticancer Res (2011) 0.93
Treatment planning for the layer-stacking irradiation system for three-dimensional conformal heavy-ion radiotherapy. Med Phys (2002) 0.93
Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia. Esophagus (2013) 0.93
Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int J Radiat Oncol Biol Phys (2010) 0.93
Japanese structure survey of radiation oncology in 2007 based on institutional stratification of patterns of care study. Int J Radiat Oncol Biol Phys (2010) 0.93
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer (2014) 0.93
Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma. Lung Cancer (2010) 0.92
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients. Cancer Chemother Pharmacol (2010) 0.92
Asthma: Chronopharmacotherapy and the molecular clock. Adv Drug Deliv Rev (2010) 0.92
Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer. Int J Cancer (2012) 0.92
Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors. Lung Cancer (2011) 0.91
Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma. Med Oncol (2011) 0.91
Circadian rhythms in the CNS and peripheral clock disorders: function of clock genes: influence of medication for bronchial asthma on circadian gene. J Pharmacol Sci (2007) 0.91
Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells. J Neurosci Res (2005) 0.91
Occurrence and clinical features of brain metastasis after chemoradiotherapy for esophageal carcinoma. J Radiat Res (2011) 0.91
Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta. Int J Clin Oncol (2011) 0.91
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial. BMC Cancer (2012) 0.91
Leptomeningeal carcinomatosis associated with gastric cancer. Int J Clin Oncol (2011) 0.91
Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis. World J Surg (2012) 0.90
Approximate entropy of the electroencephalogram in healthy awake subjects and absence epilepsy patients. Clin EEG Neurosci (2005) 0.90
Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Int J Oncol (2013) 0.90
18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study. Eur J Radiol (2011) 0.90
Cardiac imaging using 256-detector row four-dimensional CT: preliminary clinical report. Radiat Med (2007) 0.90
The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer (2014) 0.89
Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg (2010) 0.89
Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer. Anticancer Res (2011) 0.89
Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer. Lung Cancer (2009) 0.89
18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. Ann Nucl Med (2010) 0.89
Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro. Chronobiol Int (2005) 0.88